Marketing Intern- FUROSCIX

Burlington, MA (Hybrid)

Salary Not AvailableIntern/New GradFull time

Posted 4 months ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Drive ML/AI tactical assessments for pharma marketing campaigns.

  • Own ML/AI tactical assessments for leads/media/social campaigns aligned with pharma guidelines
  • Must-have: Analytical competencies and trend spotting with limited information
  • Standout: Ability to conceive ideas and execute seamlessly; cross-functional impact

Job Description

Responsibilities

  • Help develop best practice/innovative machine learning and AI tactical assessments for leads/media/social campaigns that are aligned with pharma guidelines
  • Identifying novel ways to reach Healthcare Providers (HCPs) and Patients through digital channels
  • Conduct market landscape assessments as well as competitive reviews of HCP marketing tactics to identify new opportunities to leverage.
  • Evaluating cost‑efficient strategies to support the development of tactics that address common hurdles to further FUROSCIX adoption.
  • Assisting in the creation of a clear, simple, and unified framework to track and monitor the performance of key marketing initiatives.
  • Mapping emerging customer consumption trends and helping determine what needs to be built today to support future prescribing and buying behaviors.
  • Other duties as assigned

Requirements

  • Analytical competencies.
  • Ability to think outside of the box.
  • Ability to both conceive ideas but also execute seamlessly.
  • Strong ability to spot trends with limited information and conceive new ways prepare for future trends.

Preferred

  • Currently, pursuing a Bachelor’s or Master’s degree in Business, Marketing, interest or experience in Digital Marketing would be a plus.
  • Preferably within 1-2 years of graduation or pursing a post-grad program
MannKind Corporation logo

MannKind Corporation

3.6 Glassdoor

MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, we develop and commercialize treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.With deep expertise in drug-device combinations, MannKind aims to deliver therapies designed to fit seamlessly into daily life.Please visit mannkindcorp.com to learn more.

Founded in 1991
Danbury, Connecticut, USA
803 employees (22 in marketing)
79% recommend to a friend
85% CEO approval

Traffic Signals

Monthly Visitors
14.4K
Traffic Source Mix
Search
45%
Direct
40.4%
Referral
7.5%
Social
5.6%
Paid
1.4%

Headcount Trend

Current headcount: ~803

Marketing Team

Marketing Team Size
12 (1% of company)
Median Career Experience
21.5 years
Median Tenure
1.8 years
Marketing Roles Posted (Last 30 Days)
1

Funding

Total Funding
$475M
Last Raise
$75M
Post IPO Debt, 7 months ago

Funding History

  • Aug 2025
    Post IPO Debt • $75M
  • Mar 2021
    Post IPO Debt • $200M
  • Dec 2018
    Post IPO Equity • $40M

Recent News